These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29397905)

  • 1. C5a receptor targeting of partial non-structural protein 3 of dengue virus promotes antigen-specific IFN-γ-producing T-cell responses in a mucosal dengue vaccine model.
    Kim SH; Kim YN; Kim J; Jang YS
    Cell Immunol; 2018 Mar; 325():41-47. PubMed ID: 29397905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C5a receptor-targeting ligand-mediated delivery of dengue virus antigen to M cells evokes antigen-specific systemic and mucosal immune responses in oral immunization.
    Kim SH; Yang IY; Jang SH; Kim J; Truong TT; Van Pham T; Truong NU; Lee KY; Jang YS
    Microbes Infect; 2013 Nov; 15(13):895-902. PubMed ID: 23892099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of an M-cell-targeting ligand for oral vaccination induces efficient systemic and mucosal immune responses against a viral antigen.
    Kim SH; Jung DI; Yang IY; Jang SH; Kim J; Truong TT; Pham TV; Truong NU; Lee KY; Jang YS
    Int Immunol; 2013 Nov; 25(11):623-32. PubMed ID: 23900425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and immunogenicity of two new HLA-A*0201-restricted CD8+ T-cell epitopes on dengue NS1 protein.
    Tian J; Zeng G; Pang X; Liang M; Zhou J; Fang D; Liu Y; Li D; Jiang L
    Int Immunol; 2012 Apr; 24(4):207-18. PubMed ID: 22298881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India.
    Chandele A; Sewatanon J; Gunisetty S; Singla M; Onlamoon N; Akondy RS; Kissick HT; Nayak K; Reddy ES; Kalam H; Kumar D; Verma A; Panda H; Wang S; Angkasekwinai N; Pattanapanyasat K; Chokephaibulkit K; Medigeshi GR; Lodha R; Kabra S; Ahmed R; Murali-Krishna K
    J Virol; 2016 Dec; 90(24):11259-11278. PubMed ID: 27707928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cell-surface displayed synthetic consensus dengue EDIII cells as a potent oral vaccine candidate.
    Bal J; Jung HY; Nguyen LN; Park J; Jang YS; Kim DH
    Microb Cell Fact; 2018 Sep; 17(1):146. PubMed ID: 30217208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The M cell-targeting ligand promotes antigen delivery and induces antigen-specific immune responses in mucosal vaccination.
    Kim SH; Seo KW; Kim J; Lee KY; Jang YS
    J Immunol; 2010 Nov; 185(10):5787-95. PubMed ID: 20952686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential humoral and cellular immunity induced by vaccination using plasmid DNA and protein recombinant expressing the NS3 protein of dengue virus type 3.
    Hurtado-Melgoza ML; Ramos-Ligonio A; Álvarez-Rodríguez LM; Meza-Menchaca T; López-Monteon A
    J Biomed Sci; 2016 Dec; 23(1):85. PubMed ID: 27903271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes.
    Gao G; Wang Q; Dai Z; Calcedo R; Sun X; Li G; Wilson JM
    Hum Gene Ther; 2008 Sep; 19(9):927-36. PubMed ID: 18788905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and characterization of an M cell-specific ligand-fused dengue virus tetravalent epitope using Saccharomyces cerevisiae.
    Nguyen NL; So KK; Kim JM; Kim SH; Jang YS; Yang MS; Kim DH
    J Biosci Bioeng; 2015 Jan; 119(1):19-27. PubMed ID: 25027708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis model.
    Amorim JH; dos Santos Alves RP; Bizerra R; Araújo Pereira S; Ramos Pereira L; Nascimento Fabris DL; Santos RA; Romano CM; de Souza Ferreira LC
    Virology; 2016 Jan; 487():41-9. PubMed ID: 26496698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.
    Hu Z; Wong KW; Zhao HM; Wen HL; Ji P; Ma H; Wu K; Lu SH; Li F; Li ZM; Shu T; Xu JQ; Lowrie DB; Fan XY
    Mol Ther; 2017 May; 25(5):1222-1233. PubMed ID: 28342639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inferring Protective CD8+ T-Cell Epitopes for NS5 Protein of Four Serotypes of Dengue Virus Chinese Isolates Based on HLA-A, -B and -C Allelic Distribution: Implications for Epitope-Based Universal Vaccine Design.
    Shi J; Sun J; Wu M; Hu N; Li J; Li Y; Wang H; Hu Y
    PLoS One; 2015; 10(9):e0138729. PubMed ID: 26381649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ T-cell Responses in Flavivirus-Naive Individuals Following Immunization with a Live-Attenuated Tetravalent Dengue Vaccine Candidate.
    Chu H; George SL; Stinchcomb DT; Osorio JE; Partidos CD
    J Infect Dis; 2015 Nov; 212(10):1618-28. PubMed ID: 25943203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice.
    Gil L; López C; Lazo L; Valdés I; Marcos E; Alonso R; Gambe A; Martín J; Romero Y; Guzmán MG; Guillén G; Hermida L
    Int Immunol; 2009 Oct; 21(10):1175-83. PubMed ID: 19692540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspects of T Cell-Mediated Immunity Induced in Mice by a DNA Vaccine Based on the Dengue-NS1 Antigen after Challenge by the Intracerebral Route.
    Oliveira ER; Gonçalves AJ; Costa SM; Azevedo AS; Mantuano-Barradas M; Nogueira AC; Alves AM
    PLoS One; 2016; 11(9):e0163240. PubMed ID: 27631083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intact signal peptide on dengue virus E protein enhances immunogenicity for CD8(+) T cells and antibody when expressed from modified vaccinia Ankara.
    Quinan BR; Flesch IE; Pinho TM; Coelho FM; Tscharke DC; da Fonseca FG
    Vaccine; 2014 May; 32(25):2972-9. PubMed ID: 24726244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion.
    Sullivan NL; Eickhoff CS; Sagartz J; Hoft DF
    J Immunol; 2015 Feb; 194(4):1806-18. PubMed ID: 25595788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.